nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—CYP1B1—Mitoxantrone—lymphatic system cancer	0.276	0.35	CbGbCtD
Theophylline—CYP1A2—Carmustine—lymphatic system cancer	0.115	0.146	CbGbCtD
Theophylline—SLC22A7—Methotrexate—lymphatic system cancer	0.104	0.132	CbGbCtD
Theophylline—CYP2E1—Mitoxantrone—lymphatic system cancer	0.0934	0.119	CbGbCtD
Theophylline—CYP2C9—Teniposide—lymphatic system cancer	0.0696	0.0885	CbGbCtD
Theophylline—CYP3A4—Cytarabine—lymphatic system cancer	0.0411	0.0522	CbGbCtD
Theophylline—CYP3A4—Teniposide—lymphatic system cancer	0.0405	0.0514	CbGbCtD
Theophylline—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0283	0.036	CbGbCtD
Theophylline—CYP3A4—Vincristine—lymphatic system cancer	0.0195	0.0248	CbGbCtD
Theophylline—Supraventricular tachycardia—Fludarabine—lymphatic system cancer	0.00518	0.0243	CcSEcCtD
Theophylline—Extravasation—Teniposide—lymphatic system cancer	0.00443	0.0207	CcSEcCtD
Theophylline—Epigastric pain—Mitoxantrone—lymphatic system cancer	0.00418	0.0196	CcSEcCtD
Theophylline—Hyperuricaemia—Fludarabine—lymphatic system cancer	0.00366	0.0171	CcSEcCtD
Theophylline—Inappropriate antidiuretic hormone secretion—Vincristine—lymphatic system cancer	0.00357	0.0167	CcSEcCtD
Theophylline—Blood uric acid increased—Fludarabine—lymphatic system cancer	0.00346	0.0162	CcSEcCtD
Theophylline—Phlebitis—Teniposide—lymphatic system cancer	0.00325	0.0152	CcSEcCtD
Theophylline—Coma—Fludarabine—lymphatic system cancer	0.0031	0.0145	CcSEcCtD
Theophylline—Phlebitis—Fludarabine—lymphatic system cancer	0.00286	0.0134	CcSEcCtD
Theophylline—Extravasation—Bleomycin—lymphatic system cancer	0.00285	0.0134	CcSEcCtD
Theophylline—Extravasation—Carmustine—lymphatic system cancer	0.00249	0.0117	CcSEcCtD
Theophylline—Extravasation—Vincristine—lymphatic system cancer	0.00238	0.0111	CcSEcCtD
Theophylline—Alopecia—Mechlorethamine—lymphatic system cancer	0.00232	0.0109	CcSEcCtD
Theophylline—Extravasation—Mitoxantrone—lymphatic system cancer	0.00231	0.0108	CcSEcCtD
Theophylline—Hyperuricaemia—Vincristine—lymphatic system cancer	0.00224	0.0105	CcSEcCtD
Theophylline—Hyperuricaemia—Mitoxantrone—lymphatic system cancer	0.00218	0.0102	CcSEcCtD
Theophylline—Blood uric acid increased—Vincristine—lymphatic system cancer	0.00211	0.0099	CcSEcCtD
Theophylline—Phlebitis—Bleomycin—lymphatic system cancer	0.0021	0.00983	CcSEcCtD
Theophylline—Blood uric acid increased—Mitoxantrone—lymphatic system cancer	0.00206	0.00964	CcSEcCtD
Theophylline—Disorientation—Bleomycin—lymphatic system cancer	0.00202	0.00946	CcSEcCtD
Theophylline—Coma—Carmustine—lymphatic system cancer	0.00199	0.0093	CcSEcCtD
Theophylline—Hyperglycaemia—Fludarabine—lymphatic system cancer	0.00192	0.009	CcSEcCtD
Theophylline—Coma—Vincristine—lymphatic system cancer	0.00189	0.00888	CcSEcCtD
Theophylline—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00187	0.00876	CcSEcCtD
Theophylline—Infection—Mechlorethamine—lymphatic system cancer	0.00186	0.0087	CcSEcCtD
Theophylline—Phlebitis—Carmustine—lymphatic system cancer	0.00183	0.00858	CcSEcCtD
Theophylline—Haematuria—Fludarabine—lymphatic system cancer	0.00181	0.00848	CcSEcCtD
Theophylline—Flushing—Teniposide—lymphatic system cancer	0.0018	0.00844	CcSEcCtD
Theophylline—Anorexia—Mechlorethamine—lymphatic system cancer	0.00178	0.00835	CcSEcCtD
Theophylline—Arrhythmia—Teniposide—lymphatic system cancer	0.00173	0.00812	CcSEcCtD
Theophylline—Polyuria—Vincristine—lymphatic system cancer	0.00171	0.00803	CcSEcCtD
Theophylline—Alopecia—Teniposide—lymphatic system cancer	0.00171	0.00803	CcSEcCtD
Theophylline—Phlebitis—Mitoxantrone—lymphatic system cancer	0.0017	0.00797	CcSEcCtD
Theophylline—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00162	0.00761	CcSEcCtD
Theophylline—Agitation—Teniposide—lymphatic system cancer	0.00155	0.00727	CcSEcCtD
Theophylline—Arrhythmia—Fludarabine—lymphatic system cancer	0.00152	0.00714	CcSEcCtD
Theophylline—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00151	0.0071	CcSEcCtD
Theophylline—Alopecia—Fludarabine—lymphatic system cancer	0.00151	0.00706	CcSEcCtD
Theophylline—Haematemesis—Methotrexate—lymphatic system cancer	0.00145	0.00679	CcSEcCtD
Theophylline—Hypokalaemia—Carmustine—lymphatic system cancer	0.00144	0.00673	CcSEcCtD
Theophylline—Urinary retention—Vincristine—lymphatic system cancer	0.00143	0.00671	CcSEcCtD
Theophylline—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00138	0.00645	CcSEcCtD
Theophylline—Infection—Teniposide—lymphatic system cancer	0.00137	0.00641	CcSEcCtD
Theophylline—Agitation—Fludarabine—lymphatic system cancer	0.00136	0.00639	CcSEcCtD
Theophylline—Tachycardia—Teniposide—lymphatic system cancer	0.00134	0.0063	CcSEcCtD
Theophylline—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00134	0.00627	CcSEcCtD
Theophylline—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.00133	0.00625	CcSEcCtD
Theophylline—Haematuria—Bleomycin—lymphatic system cancer	0.00133	0.00622	CcSEcCtD
Theophylline—Pruritus—Mechlorethamine—lymphatic system cancer	0.00132	0.0062	CcSEcCtD
Theophylline—Anorexia—Teniposide—lymphatic system cancer	0.00131	0.00616	CcSEcCtD
Theophylline—Hypotension—Teniposide—lymphatic system cancer	0.00129	0.00603	CcSEcCtD
Theophylline—Convulsion—Fludarabine—lymphatic system cancer	0.00129	0.00602	CcSEcCtD
Theophylline—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00128	0.00599	CcSEcCtD
Theophylline—Hyperglycaemia—Carmustine—lymphatic system cancer	0.00123	0.00576	CcSEcCtD
Theophylline—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00121	0.00568	CcSEcCtD
Theophylline—Infection—Fludarabine—lymphatic system cancer	0.0012	0.00564	CcSEcCtD
Theophylline—Decreased appetite—Teniposide—lymphatic system cancer	0.0012	0.00561	CcSEcCtD
Theophylline—Vomiting—Mechlorethamine—lymphatic system cancer	0.00119	0.00557	CcSEcCtD
Theophylline—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00119	0.00557	CcSEcCtD
Theophylline—Rash—Mechlorethamine—lymphatic system cancer	0.00118	0.00552	CcSEcCtD
Theophylline—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00118	0.00552	CcSEcCtD
Theophylline—Flushing—Bleomycin—lymphatic system cancer	0.00116	0.00544	CcSEcCtD
Theophylline—Anorexia—Fludarabine—lymphatic system cancer	0.00115	0.00541	CcSEcCtD
Theophylline—Extravasation—Methotrexate—lymphatic system cancer	0.00115	0.0054	CcSEcCtD
Theophylline—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00114	0.00536	CcSEcCtD
Theophylline—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00113	0.00528	CcSEcCtD
Theophylline—Nausea—Mechlorethamine—lymphatic system cancer	0.00111	0.0052	CcSEcCtD
Theophylline—Alopecia—Bleomycin—lymphatic system cancer	0.0011	0.00518	CcSEcCtD
Theophylline—Urticaria—Teniposide—lymphatic system cancer	0.00109	0.00513	CcSEcCtD
Theophylline—Abdominal pain—Teniposide—lymphatic system cancer	0.00109	0.0051	CcSEcCtD
Theophylline—Body temperature increased—Teniposide—lymphatic system cancer	0.00109	0.0051	CcSEcCtD
Theophylline—Hyperuricaemia—Methotrexate—lymphatic system cancer	0.00108	0.00508	CcSEcCtD
Theophylline—Haematuria—Mitoxantrone—lymphatic system cancer	0.00108	0.00505	CcSEcCtD
Theophylline—Decreased appetite—Fludarabine—lymphatic system cancer	0.00105	0.00493	CcSEcCtD
Theophylline—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.00102	0.0048	CcSEcCtD
Theophylline—Hypersensitivity—Teniposide—lymphatic system cancer	0.00102	0.00476	CcSEcCtD
Theophylline—Flushing—Carmustine—lymphatic system cancer	0.00101	0.00474	CcSEcCtD
Theophylline—Pruritus—Teniposide—lymphatic system cancer	0.000975	0.00457	CcSEcCtD
Theophylline—Arrhythmia—Carmustine—lymphatic system cancer	0.000975	0.00457	CcSEcCtD
Theophylline—Alopecia—Carmustine—lymphatic system cancer	0.000964	0.00452	CcSEcCtD
Theophylline—Body temperature increased—Fludarabine—lymphatic system cancer	0.000957	0.00449	CcSEcCtD
Theophylline—Diarrhoea—Teniposide—lymphatic system cancer	0.000943	0.00442	CcSEcCtD
Theophylline—Alopecia—Vincristine—lymphatic system cancer	0.00092	0.00431	CcSEcCtD
Theophylline—Coma—Methotrexate—lymphatic system cancer	0.000919	0.00431	CcSEcCtD
Theophylline—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000906	0.00425	CcSEcCtD
Theophylline—Alopecia—Mitoxantrone—lymphatic system cancer	0.000896	0.0042	CcSEcCtD
Theophylline—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000892	0.00418	CcSEcCtD
Theophylline—Tremor—Carmustine—lymphatic system cancer	0.00089	0.00417	CcSEcCtD
Theophylline—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000888	0.00416	CcSEcCtD
Theophylline—Infection—Bleomycin—lymphatic system cancer	0.000882	0.00413	CcSEcCtD
Theophylline—Vomiting—Teniposide—lymphatic system cancer	0.000876	0.00411	CcSEcCtD
Theophylline—Agitation—Carmustine—lymphatic system cancer	0.000873	0.00409	CcSEcCtD
Theophylline—Rash—Teniposide—lymphatic system cancer	0.000869	0.00407	CcSEcCtD
Theophylline—Dermatitis—Teniposide—lymphatic system cancer	0.000868	0.00407	CcSEcCtD
Theophylline—Headache—Teniposide—lymphatic system cancer	0.000863	0.00405	CcSEcCtD
Theophylline—Pruritus—Fludarabine—lymphatic system cancer	0.000857	0.00402	CcSEcCtD
Theophylline—Anorexia—Bleomycin—lymphatic system cancer	0.000846	0.00397	CcSEcCtD
Theophylline—Agitation—Vincristine—lymphatic system cancer	0.000833	0.0039	CcSEcCtD
Theophylline—Polyuria—Methotrexate—lymphatic system cancer	0.000832	0.0039	CcSEcCtD
Theophylline—Hypotension—Bleomycin—lymphatic system cancer	0.00083	0.00389	CcSEcCtD
Theophylline—Diarrhoea—Fludarabine—lymphatic system cancer	0.000829	0.00388	CcSEcCtD
Theophylline—Convulsion—Carmustine—lymphatic system cancer	0.000823	0.00386	CcSEcCtD
Theophylline—Nausea—Teniposide—lymphatic system cancer	0.000818	0.00384	CcSEcCtD
Theophylline—Anxiety—Carmustine—lymphatic system cancer	0.000806	0.00378	CcSEcCtD
Theophylline—Convulsion—Vincristine—lymphatic system cancer	0.000785	0.00368	CcSEcCtD
Theophylline—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000774	0.00363	CcSEcCtD
Theophylline—Decreased appetite—Bleomycin—lymphatic system cancer	0.000772	0.00362	CcSEcCtD
Theophylline—Infection—Carmustine—lymphatic system cancer	0.00077	0.00361	CcSEcCtD
Theophylline—Vomiting—Fludarabine—lymphatic system cancer	0.00077	0.00361	CcSEcCtD
Theophylline—Convulsion—Mitoxantrone—lymphatic system cancer	0.000765	0.00358	CcSEcCtD
Theophylline—Rash—Fludarabine—lymphatic system cancer	0.000764	0.00358	CcSEcCtD
Theophylline—Dermatitis—Fludarabine—lymphatic system cancer	0.000763	0.00357	CcSEcCtD
Theophylline—Headache—Fludarabine—lymphatic system cancer	0.000759	0.00356	CcSEcCtD
Theophylline—Tachycardia—Carmustine—lymphatic system cancer	0.000756	0.00354	CcSEcCtD
Theophylline—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000755	0.00354	CcSEcCtD
Theophylline—Anxiety—Mitoxantrone—lymphatic system cancer	0.000749	0.00351	CcSEcCtD
Theophylline—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00074	0.00347	CcSEcCtD
Theophylline—Anorexia—Carmustine—lymphatic system cancer	0.000739	0.00346	CcSEcCtD
Theophylline—Infection—Vincristine—lymphatic system cancer	0.000735	0.00344	CcSEcCtD
Theophylline—Nervous system disorder—Vincristine—lymphatic system cancer	0.000726	0.0034	CcSEcCtD
Theophylline—Hypotension—Carmustine—lymphatic system cancer	0.000724	0.00339	CcSEcCtD
Theophylline—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000721	0.00338	CcSEcCtD
Theophylline—Nausea—Fludarabine—lymphatic system cancer	0.000719	0.00337	CcSEcCtD
Theophylline—Infection—Mitoxantrone—lymphatic system cancer	0.000716	0.00335	CcSEcCtD
Theophylline—Shock—Mitoxantrone—lymphatic system cancer	0.000709	0.00332	CcSEcCtD
Theophylline—Urticaria—Bleomycin—lymphatic system cancer	0.000705	0.00331	CcSEcCtD
Theophylline—Anorexia—Vincristine—lymphatic system cancer	0.000705	0.0033	CcSEcCtD
Theophylline—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000703	0.0033	CcSEcCtD
Theophylline—Body temperature increased—Bleomycin—lymphatic system cancer	0.000702	0.00329	CcSEcCtD
Theophylline—Insomnia—Carmustine—lymphatic system cancer	0.000701	0.00329	CcSEcCtD
Theophylline—Irritability—Methotrexate—lymphatic system cancer	0.000697	0.00327	CcSEcCtD
Theophylline—Hypotension—Vincristine—lymphatic system cancer	0.000691	0.00324	CcSEcCtD
Theophylline—Anorexia—Mitoxantrone—lymphatic system cancer	0.000687	0.00322	CcSEcCtD
Theophylline—Decreased appetite—Carmustine—lymphatic system cancer	0.000674	0.00316	CcSEcCtD
Theophylline—Hypotension—Mitoxantrone—lymphatic system cancer	0.000673	0.00316	CcSEcCtD
Theophylline—Insomnia—Vincristine—lymphatic system cancer	0.000669	0.00314	CcSEcCtD
Theophylline—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000654	0.00307	CcSEcCtD
Theophylline—Decreased appetite—Vincristine—lymphatic system cancer	0.000643	0.00301	CcSEcCtD
Theophylline—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000634	0.00297	CcSEcCtD
Theophylline—Pruritus—Bleomycin—lymphatic system cancer	0.000628	0.00294	CcSEcCtD
Theophylline—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000626	0.00294	CcSEcCtD
Theophylline—Body temperature increased—Carmustine—lymphatic system cancer	0.000613	0.00287	CcSEcCtD
Theophylline—Abdominal pain—Carmustine—lymphatic system cancer	0.000613	0.00287	CcSEcCtD
Theophylline—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000605	0.00284	CcSEcCtD
Theophylline—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000589	0.00276	CcSEcCtD
Theophylline—Body temperature increased—Vincristine—lymphatic system cancer	0.000585	0.00274	CcSEcCtD
Theophylline—Abdominal pain—Vincristine—lymphatic system cancer	0.000585	0.00274	CcSEcCtD
Theophylline—Urticaria—Mitoxantrone—lymphatic system cancer	0.000572	0.00268	CcSEcCtD
Theophylline—Hypersensitivity—Carmustine—lymphatic system cancer	0.000571	0.00268	CcSEcCtD
Theophylline—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00057	0.00267	CcSEcCtD
Theophylline—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00057	0.00267	CcSEcCtD
Theophylline—Vomiting—Bleomycin—lymphatic system cancer	0.000565	0.00265	CcSEcCtD
Theophylline—Rash—Bleomycin—lymphatic system cancer	0.00056	0.00262	CcSEcCtD
Theophylline—Dermatitis—Bleomycin—lymphatic system cancer	0.000559	0.00262	CcSEcCtD
Theophylline—Hypersensitivity—Vincristine—lymphatic system cancer	0.000545	0.00255	CcSEcCtD
Theophylline—Haematuria—Methotrexate—lymphatic system cancer	0.000537	0.00252	CcSEcCtD
Theophylline—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000531	0.00249	CcSEcCtD
Theophylline—Diarrhoea—Carmustine—lymphatic system cancer	0.00053	0.00249	CcSEcCtD
Theophylline—Nausea—Bleomycin—lymphatic system cancer	0.000527	0.00247	CcSEcCtD
Theophylline—Dizziness—Carmustine—lymphatic system cancer	0.000513	0.0024	CcSEcCtD
Theophylline—Diarrhoea—Vincristine—lymphatic system cancer	0.000506	0.00237	CcSEcCtD
Theophylline—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000493	0.00231	CcSEcCtD
Theophylline—Vomiting—Carmustine—lymphatic system cancer	0.000493	0.00231	CcSEcCtD
Theophylline—Dizziness—Vincristine—lymphatic system cancer	0.000489	0.00229	CcSEcCtD
Theophylline—Rash—Carmustine—lymphatic system cancer	0.000489	0.00229	CcSEcCtD
Theophylline—Dermatitis—Carmustine—lymphatic system cancer	0.000488	0.00229	CcSEcCtD
Theophylline—Headache—Carmustine—lymphatic system cancer	0.000486	0.00228	CcSEcCtD
Theophylline—Vomiting—Vincristine—lymphatic system cancer	0.00047	0.0022	CcSEcCtD
Theophylline—Rash—Vincristine—lymphatic system cancer	0.000466	0.00219	CcSEcCtD
Theophylline—Dermatitis—Vincristine—lymphatic system cancer	0.000466	0.00218	CcSEcCtD
Theophylline—Headache—Vincristine—lymphatic system cancer	0.000463	0.00217	CcSEcCtD
Theophylline—Nausea—Carmustine—lymphatic system cancer	0.00046	0.00216	CcSEcCtD
Theophylline—Vomiting—Mitoxantrone—lymphatic system cancer	0.000458	0.00215	CcSEcCtD
Theophylline—Rash—Mitoxantrone—lymphatic system cancer	0.000454	0.00213	CcSEcCtD
Theophylline—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000454	0.00213	CcSEcCtD
Theophylline—Headache—Mitoxantrone—lymphatic system cancer	0.000451	0.00212	CcSEcCtD
Theophylline—Alopecia—Methotrexate—lymphatic system cancer	0.000447	0.00209	CcSEcCtD
Theophylline—Nausea—Vincristine—lymphatic system cancer	0.000439	0.00206	CcSEcCtD
Theophylline—Nausea—Mitoxantrone—lymphatic system cancer	0.000428	0.00201	CcSEcCtD
Theophylline—Convulsion—Methotrexate—lymphatic system cancer	0.000381	0.00179	CcSEcCtD
Theophylline—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000359	0.00168	CcSEcCtD
Theophylline—Infection—Methotrexate—lymphatic system cancer	0.000357	0.00167	CcSEcCtD
Theophylline—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000352	0.00165	CcSEcCtD
Theophylline—Anorexia—Methotrexate—lymphatic system cancer	0.000342	0.0016	CcSEcCtD
Theophylline—Hypotension—Methotrexate—lymphatic system cancer	0.000335	0.00157	CcSEcCtD
Theophylline—Insomnia—Methotrexate—lymphatic system cancer	0.000325	0.00152	CcSEcCtD
Theophylline—Decreased appetite—Methotrexate—lymphatic system cancer	0.000312	0.00146	CcSEcCtD
Theophylline—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000294	0.00138	CcSEcCtD
Theophylline—Urticaria—Methotrexate—lymphatic system cancer	0.000285	0.00134	CcSEcCtD
Theophylline—Abdominal pain—Methotrexate—lymphatic system cancer	0.000284	0.00133	CcSEcCtD
Theophylline—Body temperature increased—Methotrexate—lymphatic system cancer	0.000284	0.00133	CcSEcCtD
Theophylline—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000264	0.00124	CcSEcCtD
Theophylline—Pruritus—Methotrexate—lymphatic system cancer	0.000254	0.00119	CcSEcCtD
Theophylline—Diarrhoea—Methotrexate—lymphatic system cancer	0.000246	0.00115	CcSEcCtD
Theophylline—Dizziness—Methotrexate—lymphatic system cancer	0.000237	0.00111	CcSEcCtD
Theophylline—Vomiting—Methotrexate—lymphatic system cancer	0.000228	0.00107	CcSEcCtD
Theophylline—Rash—Methotrexate—lymphatic system cancer	0.000226	0.00106	CcSEcCtD
Theophylline—Dermatitis—Methotrexate—lymphatic system cancer	0.000226	0.00106	CcSEcCtD
Theophylline—Headache—Methotrexate—lymphatic system cancer	0.000225	0.00105	CcSEcCtD
Theophylline—Nausea—Methotrexate—lymphatic system cancer	0.000213	0.000999	CcSEcCtD
